Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSuzhou Hengruihongyuan Medical Technology Co. LTD
About this trial
The purpose of this study is to evaluate the effectiveness and safety of the suture-mediated closure system produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. following Percutaneous Common Femoral Vein Procedures.
Eligibility criteria
Qualifiers
Aged 18 to 80 years
Patients eligible for interventional catheter-based examination or treatment via common femoral artery puncture using sheaths sized 5F to 21F
Signed by the patient personally or by their legal representative on the Informed Consent Form
Disqualifiers
Known pregnancy or lactation period;
Diameter of the common femoral artery on the puncture side < 5 mm;
Concurrent participation in another clinical research study;
Known allergy to any device component, and/or contraindications to contrast agents or anticoagulants;
Trial design
Treatments tested in this trial
- SPIDER
- Perclose ProGlide
Treatment groups
136 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov